Sampre Nutritions Ltd (SAMPRE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sampre Nutritions Ltd on NSE and BSE, with an AI summary of each filing.
Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve unaudited standalone and ....
Intimation · 06 Nov 2026, 5:30 am
Sampre Nutritions to Consider Q2 FY27 Financial Results on 6th Nov'26 Sampre Nutritions Limited has informed BSE that a meeting of its Board of Directors is scheduled for 6th Nov'26. The board will, inter alia, consider and approve the unaudited standalone and consolidated financial results of the company for the second quarter ended 30th Sep'26 for FY27.
Allotment of 1770710 fully paid-up equity shares having a face value of INR 5 each at an issue price of INR 42 each, including a premium of INR 37 each, aggregating to INR 7,43,69,820 only ....
Others (Uncategorized) · 25 Sept 2026, 11:59 pm
Sampre Nutritions Approves INR 7.44 Cr Preferential Equity Allotment on Loan Conversion Sampre Nutritions approved the preferential allotment of 17,70,710 equity shares (face value INR 5) at INR 42 each (including an INR 37 premium), aggregating to INR 7.44 cr via conversion of unsecured loans on 25th Sep'26. Shares were allotted to promoters Brahma Gurbani (16,93,880 shares) and Meera Gurbani (76,830 shares). Post-allotment, Brahma Gurbani's stake increases from 5.84% to 7.48%, while Meera Gurbani's stake rises slightly from 3.46% to 3.47%. The issuance follows shareholder approval on 10th Dec'25 and BSE in-principle approval on 28th Aug'26.
Consolidated Voting Results with the Scrutinizers Report for the 35th Annual General Meeting.
Annual General Meeting · 06 Sept 2026, 12:58 am
Proceedings of the 35th AGM conducted through Video Conferencing ("VC") / Other Audio-Visual Mode ("OAVM")
Annual General Meeting · 04 Sept 2026, 6:08 pm
Receipt of in-principle / prior approval from BSE for issuance and allotment of 1770710 equity shares of INR 5 each at a price not less than INR 42 each to promoter against conversion of ....
Others (Uncategorized) · 30 Aug 2026, 12:03 am
Sampre Nutritions Receives BSE Approval for Preferential Share Issue Sampre Nutritions received in-principle approval from the BSE on 28 Aug'26 to issue 17,70,710 equity shares to its promoter group on a preferential basis. The shares, with a face value of Rs. 5 each, will be issued at a price not less than Rs. 42 per share. This preferential allotment is against the conversion of an unsecured loan aggregating to Rs. 7.44 Cr. The transaction serves to convert promoter debt into equity, thereby strengthening the company's balance sheet.
The company has dispatched the letter to all the shareholders holding shares of the company in physical form, containing a QR code that provides direct access to the Annual Report available ....
Annual General Meeting · 14 Aug 2026, 7:04 pm
This is a corrigendum to the Notice of the 35th AGM. There was a typographical error in the date of appointment of the scrutinizer. The said error has been rectified. Neither any material ....
Annual General Meeting · 14 Aug 2026, 6:56 pm
Annual report of the company for the financial year 2025-26. The intimation for the annual report and the notice of the 35th AGM together has been intimated on 10 August 2026.
Others (Uncategorized) · 11 Aug 2026, 12:32 am
Notice of the 35th AGM of the Company to be held on Friday, 04 September 2026, at 11:00 A.M. (IST), through video conferencing ("VC") / other audio-visual means ("OAVM") along with the ....
Annual General Meeting · 11 Aug 2026, 12:24 am
Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve 1. Unaudited standalone and ....
Intimation · 05 Aug 2026, 5:30 am
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 20 Jun 2026, 6:09 pm
Sampre Nutritions Confirms It Is Not A Large Corporate For FY26 Sampre Nutritions Ltd. informed the BSE on 20 Jun'26 that it does not meet the criteria to be classified as a Large Corporate for FY 2025-26, as per SEBI regulations. Consequently, the disclosure and compliance requirements mandated for Large Corporates, including the framework for mandatory borrowing through debt securities, are not applicable to the company. The company reported outstanding borrowings of ₹12.75 Cr as of Mar'24 and did not have a credit rating in the previous financial year.
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are enclosing a commemorative communication issued by the Company acknowledging approximately thirty (30) years of business ....
Others (Uncategorized) · 29 May 2026, 11:42 pm
Sampre Nutritions Marks 30-Year Business Association with Mondelez Sampre Nutritions, on 29 May'26, announced the completion of its 30-year business association with customer entity Mondelez International (1995-2025). This voluntary disclosure is for transparency and does not constitute a new material event. The company clarified there are no changes to existing business arrangements, no new financial commitments, and no forward-looking statements on revenue or profitability. The communication aims to recognize a long-standing commercial relationship without modifying current commercial terms or creating new obligations.
In compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, the audited standalone and consolidated financial results along with the independent auditor''s report, and declaration ....
Outcome · 29 May 2026, 11:10 pm
Sampre Nutritions Reports Turnaround in Q4 & FY26 with Unmodified Audit Opinion Sampre Nutritions reported a turnaround for the quarter and year ended 31 Mar'26. On a standalone basis, Q4'26 profit after tax (PAT) was ₹182.23 lakhs versus a loss of ₹714.29 lakhs YoY. FY26 PAT stood at ₹386.55 lakhs, reversing a loss of ₹730.92 lakhs in FY25. Total revenue for FY26 grew to ₹4,405.76 lakhs from ₹2,549.87 lakhs YoY. The board approved the audited standalone and consolidated results, which received an unmodified audit opinion, at its meeting on 29 May'26.
Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the audited standalone and ....
Intimation · 29 May 2026, 5:30 am
Sampre Nutritions to Announce Q4 & FY26 Results on May 29 Sampre Nutritions Limited has scheduled a Board of Directors meeting on 29 May'26. The agenda includes the consideration and approval of the audited standalone and consolidated financial results for the quarter and financial year ended 31 Mar'26. This announcement is pursuant to Regulation 29 of SEBI's Listing Regulations.
Submission of clarification under Regulation 30(11) of the SEBI (LODR) Regulations, 2015, in respect of information circulating on certain social media platforms. No such combined / joint ....
Others (Uncategorized) · 18 Feb 2026, 11:07 pm
Sampre Nutritions Denies Rumours of a Combined INR 100 Crore Deal Sampre Nutritions, on 18 Feb'26, clarified social media rumours alleging a combined deal with Reliance, Tolaram, and Rama Exports worth ~INR 100 crores over three years. The company confirmed it has separate, independent manufacturing/supply agreements with Tolaram Wellness (28 Aug'25), Rama Exports (22 Aug'25), and Reliance Consumer Products (17 Oct'25), which were previously disclosed. Sampre stated there is no joint agreement and any revenue projections circulating are speculative, unconfirmed, and not endorsed by the company. It advised investors to rely only on official exchange filings.
Appointment of Pradeep Narendra Poddar (DIN: 00025199), as an Non-Executive Non-Independent Additional Director with effect from 13 February 2026.
Change in Management · 14 Feb 2026, 1:12 am
Sampre Nutritions Q3 FY26 Results & Director Appointment Sampre Nutritions approved its Q3 FY26 unaudited standalone results on 13 Feb'26. Q3 revenue was ₹738.51 lakhs, down 26.1% QoQ but up 32.4% YoY. Net profit stood at ₹65.84 lakhs, a significant turnaround from a loss of ₹53.72 lakhs in Q3 FY25 but down 26.4% QoQ. For the nine months ended 31 Dec'25, revenue reached ₹2,824.90 lakhs with a net profit of ₹177.18 lakhs. The board also appointed Pradeep Narendra Poddar as a non-executive non-independent additional director, effective 13 Feb'26.
Board meeting outcome for standalone and consolidated unaudited financial results for the third quarter and nine-month period ended 31 December 2025; with appointment of a non-executive ....
Outcome · 14 Feb 2026, 12:37 am
SAMPRE NUTRITIONS LIMITED - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) ■ Revenue: 739 (+32.4% YoY | -26.1% QoQ) ■ EBITDA: 149 (+241.4% YoY | -23.8% QoQ) ■ EBITDA Margin (%): 20.1 (+1232 bps YoY | +60 bps QoQ) ■ PAT: 61.7 (Loss to Profit YoY | -31.1% QoQ) ■ EPS (INR): 0.06 (Loss to Profit YoY | -57.1% QoQ)
Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the unaudited standalone ....
Intimation · 13 Feb 2026, 5:30 am
Sampre Nutritions Board Meeting Set for Q3 Results Sampre Nutritions Limited's Board of Directors will meet on 13 Feb'26 to consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine-month period ended 31 Dec'25. The agenda also includes the appointment of a non-executive, non-independent additional director to the board. This meeting is scheduled pursuant to Regulation 29 of SEBI Listing Regulations.
The exchange is hereby informed that Sampre Nutrition Holdings Limited, (a wholly owned subsidiary of Sampre Nutritions Limited) has entered into a Land Purchase and Allocation Agreement ....
Others (Uncategorized) · 06 Feb 2026, 7:44 pm
Sampre Nutritions Enters Egyptian Market with Land Acquisition for New Plant Sampre Nutritions, via its wholly-owned subsidiary Sampre Nutrition Holding Ltd, has executed a Land Purchase and Allocation Agreement with Orascom Industrial Parks in Egypt on 01 Feb'26. The agreement is for acquiring an industrial land plot of 30,000 square meters. The purpose is to establish a food processing and confectionery manufacturing plant. The parties are not related, and the transaction does not fall under related party transactions, signaling a strategic international expansion for its industrial operations.
The exchange is hereby informed that the company''s Chairman and MD - Brahma Gurbani has been featured on the business magazine highlighting leadership and industry perspectives. This disclosure ....
Others (Uncategorized) · 02 Feb 2026, 9:31 pm
Sampre Nutritions Chairman Featured in Business Magazine Sampre Nutritions informed exchanges on 2 Feb'26 that its Chairman and Managing Director, Brahma Gurbani, has been featured in a business magazine. The article highlights Gurbani's leadership and industry perspectives. The company stated the disclosure is a general announcement for transparency and corporate governance and is purely informational. The attached magazine article details his role in building the Gurbani Group, a major confectionery supplier to multinational clients like Mondelez, Nestle, and Procter & Gamble, emphasizing operational excellence and global quality standards.
Conversion of 13 FCCBs to equity shares, and allotment thereof.
Others (Uncategorized) · 23 Dec 2025, 2:27 am
Sampre Nutritions Allots Equity Shares on FCCB Conversion Sampre Nutritions' board on 22 Dec'25 approved the conversion of 13 Foreign Currency Convertible Bonds (FCCBs) with a principal value of USD 1.3 million. The company allotted 7,621,493 new equity shares at a conversion price of INR 14.96 per share. Following the allotment, the paid-up share capital increased to INR 47.50 crore, comprising 95,008,913 equity shares. This action dilutes existing shareholding and expands the company's equity base. The original 100 FCCBs were allotted on 28 Jun'24.
Scrutinizers Report and Consolidated Voting Results
Extra Ordinary General Meeting · 12 Dec 2025, 5:01 pm
Sampre Nutritions Shareholders Approve All EGM Resolutions At the EGM on 10 Dec'25, shareholders approved all special resolutions with a requisite majority. Key approvals include a loan agreement with the Promoter Group and a preferential allotment of equity shares to promoters via conversion of an existing unsecured loan. Voting for both resolutions saw 12,680,028 total votes polled, representing 14.51% of total shares, with over 99.99% cast in favour. The resolutions passed successfully, securing unanimous support from both promoter and public non-institutional shareholder categories who voted.
Proceedings of the Extraordinary General Meeting of the Company conducted on Wednesday, 10 December 2025.
Extra Ordinary General Meeting · 11 Dec 2025, 4:17 am
Sampre Nutritions Limited Held EGM to Approve Loan Agreement and Equity Allotment Sampre Nutritions Limited conducted its Extraordinary General Meeting (EGM) via video conference on 10th Dec'25. The meeting, chaired by Managing Director Brahma Gurbani, had the requisite quorum and was attended by the board of directors. Members voted on two key special business items: the approval of a loan agreement between the company and its promoters/promoter group, and a proposal to offer, issue, and allot equity shares to promoters by converting an existing unsecured loan on a preferential basis. The company provided a remote e-voting facility through National Securities Depository Limited, which was open from 7th Dec'25 to 9th Dec'25, with an additional e-voting window available during the meeting. Akshita Surana & Associates were appointed as scrutinizers for the voting process.
Extraordinary General Meeting of the Company will be held on Wednesday, 10 December 2025 at 11:00 A.M. (IST) via VC/OAVM Mode.
Extra Ordinary General Meeting · 19 Nov 2025, 3:35 am
Allotment of 43693710 bonus equity shares having face value of INR 5 each, in the ratio of 1:1 to the eligible equity shareholders of the company.
Bonus Issue · 17 Nov 2025, 9:46 pm